Aphria (TSX:APHA) Earnings Drives Cannabis Stocks Higher

Shares of leading cannabis company Aphria (TSX:APHA)(NYSE:APHA) gained over 15% yesterday after its fiscal first quarter of 2020 (ended in August) results were released. Aphria reported sales of $126.1 million with adjusted earnings per share (EPS) of $0.07. Analysts estimated the firm to post revenue of $132.2 million with EPS of -$0.02. Though Aphria revenue missed estimates, it crushed the…

Read More

Did Regulators Let CannTrust (TSX:TRST) Get Off Too Easy?

CannTrust Holdings (TSX:TRST)(NYSE:CTST) shrouded the cannabis industry in scandal after authorities found secret grow rooms and unauthorized inventory in CannTrust facilities. Illegal marijuana producers use similar tactics to distribute the product in the black market. The news brought the stock down from its 52-week high of $15.50 to the current price of $1.20. Legalizing an entire industry presents many challenges,…

Read More

Will Canopy Growth (TSX:WEED) Run Out of Cash Before it Becomes Profitable?

Early investors in Canada’s legalized marijuana market have been having a horrible year. Investor sentiment in the sector seems to have moved from exuberance to utter dismay within just a few months. Cannabis companies have shed billions in value while heads have rolled at the top.  Perhaps the biggest loser this year in absolute dollar terms has been the nation’s…

Read More

Why CannTrust (TSX:TRST) Stock Fell 35% in September

Several stocks in the cannabis sector have lost considerable market value in the last 12 months. Investor optimism drove cannabis shares towards record highs prior to marijuana legalization for recreational use in Canada. Soon after, investors started to sweat over the valuations of cannabis stocks, sending them spiraling downwards. But few stocks have burnt investor money as CannTrust (TSX:TRST)(NYSE:CTST) has…

Read More

Aphria (TSX:APHA) Loses its Biggest Customer: Sell the Cannabis Stock?

News on Tuesday is that cannabis firm Aphria (TSX:APHA)(NYSE:APHA) has lost a major supply deal that could have materially benefited the company and its stock investors over the next five strong years, and the company could be liable to refund the customer and pay damages. What we know Aphria entered an initial five-year wholesale cannabis supply agreement with Emblem Corp…

Read More

Forget Canopy Growth (TSX:WEED): Why This Pot Stock Could Triple in Value!

Canopy Growth (TSX:WEED)(NYSE:CGC) has been on a rough ride this year, falling more than 45% in six months and falling to below $30 a share. While it’s likely attracted the attention of investors thinking that it could be a good buy, whether that’s the case is questionable. Let’s not forget that this is the company that is still looking for…

Read More

2 Cannabis Stocks That Could Land a Game-Changing Partner in 2020

Last year, nearly every cannabis company was racing to find a big-time partner. Cronos Group, for example, secured a $1.8 billion deal with tobacco giant Altria Group. Cronos stock ran more than 100% on the news, rising to a peak market cap of $20 billion. Canopy Growth, meanwhile, locked down a $4 billion capital infusion from Constellation Brands, causing shares…

Read More

Canopy Growth (TSX:WEED): What Can Reverse the Slide in the Stock?

It looks quite tough for investors to get excited about marijuana stocks these days after a powerful rally this year. The reflection of this thinking can be seen in the stock prices of top marijuana producers that are plunging — and not showing any sign of bottoming out. Canopy Growth (TSX:WEED)(NYSE:CGC), the world’s largest cannabis producer, has lost more than half of…

Read More

Why You’re Better off Buying Lottery Tickets Than Buying Shares of CannTrust (TSX:TRST)

In September, we learned that Health Canada was suspending CannTrust Holdings Inc‘s (TSX:TRST)(NYSE:CTST) licence to sell cannabis. The decision wasn’t a big surprise given all the scandals surrounding the company. Since that time, the stock has gone on to plummet even further in price, falling below $1.50 at writing. The $13 that the stock traded at earlier in the year…

Read More

3 Reasons Canopy Growth (TSX:WEED) Stock Is Tanking

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been having a terrible run in 2019. Having sunk to $21 on Wednesday, its returns have officially become negative for the year. The stock got off to a good start early on, rising by 75% in January. More recently, however, it has been struggling under growing losses and concerns about the quality of its management. Shortly…

Read More